[Business Wire] – DARMSTADT, Germany–(BUSINESSWIRE)– Merck’s Consumer Health division has significantly increased in size following its incorporation of Neurobion®, a leading global brand in the vitamin B segment, and Floratil®, a leading brand . . . → Read More: Company Update: Merck & Co Inc (NYSE:MRK) – Merck’s Consumer Health Division Breaks $1bn Barrier Through Transition of Neurobion and Floratil Brands from Merck Serono Similar Articles: Texas Instruments Inc (NASDAQ:TXN) – TI’s Peter Balyta to head Education Technology division; Melendy Lovett to retire Wells Fargo & Co (NYSE:WFC) – Wells Fargo director resigns for health reasons Stocks fall sharply on consumer spending worries